Zolimomab aritox (H65-RTA) 是一种免疫偶联物，由蓖麻毒素（RTA）链（一种核糖体抑制蛋白）与针对泛 T 细胞抗原CD5的单克隆抗体（H65）偶联而成。Zolimomab aritox 具有抗癌活性，可用于皮肤 T 细胞淋巴瘤研究。
| 生物活性 | Zolimomab aritox (H65-RTA) is an immunocoupling compound consisting of a ricin (RTA) chain, a ribosomal inhibitory protein, coupled to a monoclonal antibody (H65) against the pan-T-cell antigenCD5. Zolimomab aritox has anticancer activity and can be used in cutaneous T-cell lymphoma studies[1].
|
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com